March 3, 2020 / 3:35 PM / a month ago

BRIEF-Arcutis Says Data On Plaque Psoriasis Cream To Be Presented At Medical Meeting

March 3 (Reuters) - Arcutis Biotherapeutics Inc:

* ARCUTIS ANNOUNCES DATA FROM THE PHASE 2B STUDY OF TOPICAL ROFLUMILAST CREAM IN PATIENTS WITH PLAQUE PSORIASIS SELECTED FOR LATE-BREAKING ORAL PRESENTATION AT THE AMERICAN ACADEMY OF DERMATOLOGY (AAD) ANNUAL MEETING

* ARCUTIS - RESULTS FROM PHASE 1/2A STUDY OF TOPICAL ROFLUMILAST CREAM IN CHRONIC PLAQUE PSORIASIS HAVE BEEN ACCEPTED FOR AN E-POSTER PRESENTATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below